1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50.
3. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care 2016;39(Suppl 1): S13–S22.
5. International Diabetes Federation. IDF diabetes atlas. Brussels: International Diabetes Federation; 2015.
6. Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications 2008;22:317–24.
7. Khader Y, Bateiha A, El-Khateeb M, Al-Shaikh A, Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complications 2007;21:214–9.
8. Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications 2010;24:84–9.
10. Felig P, Marliss E, Ohman JL, Cahill CF Jr. Plasma amino acid levels in diabetic ketoacidosis. Diabetes 1970;19:727–8.
11. Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol 2014;2:65–75.
16. Tabish SA. Is diabetes becoming the biggest epidemic of the twentyfirst century? Int J Health Sci (Qassim) 2017;1:V–VIII.
17. Mitu O, Mitu F, Leon MM, Roca M, Gherasim A, Graur M. Increased type 2 diabetes mellitus risk (assessed by Findrisc Score) is associated with subclinical atherosclerotic markers in asymptomatic adult population. Rom J Diabetes Nutr Metab Dis 2016;23:37–45.
19. Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am 2014;43:103–22.